We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$9.6B
AUM Growth
+$506M
Cap. Flow
-$208M
Cap. Flow %
-2.17%
Top 10 Hldgs %
16.85%
Holding
2,391
New
63
Increased
104
Reduced
1,016
Closed
90

Top Buys

Rank Stock Value
1
NOW icon
ServiceNow
NOW
+$13.2M
2
BMY icon
Bristol-Myers Squibb
BMY
+$10.2M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$9.32M
4
TFC icon
Truist Financial
TFC
+$8M
5
MUB icon
iShares National Muni Bond ETF
MUB
+$6.48M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$19.2M
2
AAPL icon
Apple
AAPL
+$12M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$8.38M
4
STI
SunTrust Banks, Inc.
STI
+$8.31M
5
MSFT icon
Microsoft
MSFT
+$7.53M

Sector Composition

Rank Sector Weight
1 Technology 18.02%
2 Financials 14.83%
3 Healthcare 13.13%
4 Industrials 10.01%
5 Consumer Discretionary 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADMA icon
2301
ADMA Biologics
ADMA
$2.22B
– –
-26,341
Closed -$117K
AFMD
2302
DELISTED
Affimed
AFMD
– –
-3,269
Closed -$96.1K
AMR icon
2303
Alpha Metallurgical Resources
AMR
$1.95B
– –
-9,500
Closed -$266K
BOOM icon
2304
DMC Global
BOOM
$157M
– –
-5,631
Closed -$248K
BXC icon
2305
BlueLinx
BXC
$706M
– –
-4,247
Closed -$137K
BBBY
2306
Bed Bath & Beyond
BBBY
$407M
– –
-13,954
Closed -$111K
CNTY icon
2307
Century Casinos
CNTY
$34.3M
– –
-13,208
Closed -$102K
CVGI icon
2308
Commercial Vehicle Group
CVGI
$135M
– –
-14,605
Closed -$105K
CYCN icon
2309
Cyclerion Therapeutics
CYCN
$16.7M
– –
-630
Closed -$153K
DAKT icon
2310
Daktronics
DAKT
$1.02B
– –
-17,820
Closed -$132K
EOLS icon
2311
Evolus
EOLS
$551M
– –
-7,900
Closed -$123K
FVCB icon
2312
FVCBankcorp
FVCB
$335M
– –
-7,804
Closed -$110K
HESM icon
2313
Hess Midstream
HESM
$5.2B
– –
-50,000
Closed -$963K
IMMR icon
2314
Immersion
IMMR
$248M
– –
-15,130
Closed -$116K
ITIC
2315
Investors Title Co
ITIC
$535M
– –
-687
Closed -$110K
JYNT icon
2316
The Joint Corp
JYNT
$121M
– –
-7,132
Closed -$133K
LAB icon
2317
Standard BioTools
LAB
$309M
– –
-32,475
Closed -$150K
NERV icon
2318
Minerva Neurosciences
NERV
$206M
– –
-1,945
Closed -$121K
PTGX icon
2319
Protagonist Therapeutics
PTGX
$9.6B
– –
-9,114
Closed -$109K
QUAD icon
2320
Quad
QUAD
$502M
– –
-13,076
Closed -$137K
RBBN icon
2321
Ribbon Communications
RBBN
$356M
– –
-25,862
Closed -$151K
RCKY icon
2322
Rocky Brands
RCKY
$355M
– –
-3,479
Closed -$116K
RGCO icon
2323
RGC Resources
RGCO
$222M
– –
-3,635
Closed -$106K
SNCR
2324
DELISTED
Synchronoss Technologies
SNCR
– –
-2,029
Closed -$98.6K
SYRE icon
2325
Spyre Therapeutics
SYRE
$9.06B
– –
-565
Closed -$109K
91 92
93
94 95

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return

MetLife Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, MetLife Investment Management held 2,391 positions worth $9.6B, up 5.6% from $9.09B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

MetLife Investment Management's Q4 2019 filing shows 63 new, 104 increased, 1,016 reduced and 90 closed positions. Its largest new stake was ServiceNow: 250,510 shares worth $14.1M. The largest sale was Celgene Corp, an estimated $19.2M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2019 buy was ServiceNow: 250,510 shares worth $14.1M.
  • MetLife Investment Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $10.2M increase.
  • MetLife Investment Management's biggest Q4 2019 reduction was Apple, cutting an estimated $12M.
  • MetLife Investment Management fully exited Celgene Corp in Q4 2019, selling an estimated $19.2M.
  • MetLife Investment Management's ten largest holdings make up 17% of its $9.6B portfolio in Q4 2019.
  • MetLife Investment Management opened 63 new positions and closed 90 in Q4 2019.
  • MetLife Investment Management's portfolio value rose 5.6% quarter-over-quarter to $9.6B.

Based on MetLife Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.